IDEXX Price To Free Cash Flows Ratio from 2010 to 2025

IDXX Stock  USD 425.55  6.80  1.62%   
IDEXX Laboratories Price To Free Cash Flows Ratio yearly trend continues to be fairly stable with very little volatility. Price To Free Cash Flows Ratio is likely to outpace its year average in 2025. During the period from 2010 to 2025, IDEXX Laboratories Price To Free Cash Flows Ratio regression line of annual values had significance of  0 and arithmetic mean of  50.99. View All Fundamentals
 
Price To Free Cash Flows Ratio  
First Reported
2010-12-31
Previous Quarter
53.69
Current Value
56.37
Quarterly Volatility
26.16890859
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check IDEXX Laboratories financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among IDEXX Laboratories' main balance sheet or income statement drivers, such as Depreciation And Amortization of 138.8 M, Interest Expense of 43.4 M or Total Revenue of 4.4 B, as well as many indicators such as Price To Sales Ratio of 11.9, Dividend Yield of 0.0 or PTB Ratio of 37.5. IDEXX financial statements analysis is a perfect complement when working with IDEXX Laboratories Valuation or Volatility modules.
  
Check out the analysis of IDEXX Laboratories Correlation against competitors.
For more information on how to buy IDEXX Stock please use our How to Invest in IDEXX Laboratories guide.

Latest IDEXX Laboratories' Price To Free Cash Flows Ratio Growth Pattern

Below is the plot of the Price To Free Cash Flows Ratio of IDEXX Laboratories over the last few years. It is IDEXX Laboratories' Price To Free Cash Flows Ratio historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in IDEXX Laboratories' overall financial position and show how it may be relating to other accounts over time.
Price To Free Cash Flows Ratio10 Years Trend
Slightly volatile
   Price To Free Cash Flows Ratio   
       Timeline  

IDEXX Price To Free Cash Flows Ratio Regression Statistics

Arithmetic Mean50.99
Coefficient Of Variation51.32
Mean Deviation18.48
Median53.69
Standard Deviation26.17
Sample Variance684.81
Range108
R-Value0.73
Mean Square Error341.59
R-Squared0.53
Significance0
Slope4.02
Total Sum of Squares10,272

IDEXX Price To Free Cash Flows Ratio History

2025 56.37
2024 53.69
2023 59.65
2022 86.55
2021 88.21
2020 78.94
2019 73.99

About IDEXX Laboratories Financial Statements

IDEXX Laboratories investors use historical fundamental indicators, such as IDEXX Laboratories' Price To Free Cash Flows Ratio, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in IDEXX Laboratories. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Price To Free Cash Flows Ratio 53.69  56.37 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for IDEXX Stock Analysis

When running IDEXX Laboratories' price analysis, check to measure IDEXX Laboratories' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy IDEXX Laboratories is operating at the current time. Most of IDEXX Laboratories' value examination focuses on studying past and present price action to predict the probability of IDEXX Laboratories' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move IDEXX Laboratories' price. Additionally, you may evaluate how the addition of IDEXX Laboratories to your portfolios can decrease your overall portfolio volatility.